PCOS Treatment Using DLBS3233, Metformin, and Combination of Both

NCT01999686 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycystic Ovary Syndrome (PCOS)
Insulin Resistance

Interventions

DRUG: DLBS3233
DRUG: Metformin XR
DRUG: Placebo metformin
DRUG: Placebo DLBS3233

Sponsor

Dexa Medica Group